Rachel Klemovitch, Assistant Editor01.25.24
Leading manufacturer of heat shrink tubing for the medical industry, Cobalt Polymers, has announced new leadership to position the company for continued growth.
Bart Harris has been named general manager of the company, and Barry Schnur has been appointed interim CEO, taking over from Robert Foley.
Harris will lead a team consisting of Cheryl Morrison, who has been with Cobalt for 20 years; and Tony Martinez, a production manager with the company for 15 years.
Harris has more than two decades of experience in manufacturing, quality, and project management, with more than 15 years’ experience in medical device operations. He previously served in leadership positions at Boston Scientific and Medtronic.
Schnur will serve as interim CEO to support this transaction. He is an expert in heat shrink tubing and has played an important role in Cobalt’s growth and evolution over the past 20 years. His primary role will be CEO of Cobalt’s sales partner, David Schnur Associates (DSA).
Current president Robert Foley served the company for more than 20 years, leaving Cobalt in pursuit of other opportunities.
“On behalf of everyone at Cobalt Polymers, I want to thank Robert for his leadership and dedication over the past two decades,” Schnur said. “During Robert’s tenure, Cobalt has greatly expanded its range of heat shrink tubing, and these products have been incorporated into hundreds of successful medical devices. We’re grateful for his contributions and wish him well.”
Recently, Cobalt Polymers also made a major investment in a new facility located in Healdsburg, CA which has successfully passed the audit for ISO 13485:2026 recertification. This new facility is nearly triple the size of Cobalt’s previous space.
“The move to this beautiful new facility, together with our new operations leadership, will accelerate Cobalt’s growth and momentum,” Schnur added. “We will continue to leverage our global sales partnership with DSA and build on the customer service, quality systems and production processes that have allowed us to make heat shrink tubing products that enable incredible therapies.”
Bart Harris has been named general manager of the company, and Barry Schnur has been appointed interim CEO, taking over from Robert Foley.
Harris will lead a team consisting of Cheryl Morrison, who has been with Cobalt for 20 years; and Tony Martinez, a production manager with the company for 15 years.
Harris has more than two decades of experience in manufacturing, quality, and project management, with more than 15 years’ experience in medical device operations. He previously served in leadership positions at Boston Scientific and Medtronic.
Schnur will serve as interim CEO to support this transaction. He is an expert in heat shrink tubing and has played an important role in Cobalt’s growth and evolution over the past 20 years. His primary role will be CEO of Cobalt’s sales partner, David Schnur Associates (DSA).
Current president Robert Foley served the company for more than 20 years, leaving Cobalt in pursuit of other opportunities.
“On behalf of everyone at Cobalt Polymers, I want to thank Robert for his leadership and dedication over the past two decades,” Schnur said. “During Robert’s tenure, Cobalt has greatly expanded its range of heat shrink tubing, and these products have been incorporated into hundreds of successful medical devices. We’re grateful for his contributions and wish him well.”
Recently, Cobalt Polymers also made a major investment in a new facility located in Healdsburg, CA which has successfully passed the audit for ISO 13485:2026 recertification. This new facility is nearly triple the size of Cobalt’s previous space.
“The move to this beautiful new facility, together with our new operations leadership, will accelerate Cobalt’s growth and momentum,” Schnur added. “We will continue to leverage our global sales partnership with DSA and build on the customer service, quality systems and production processes that have allowed us to make heat shrink tubing products that enable incredible therapies.”